Results 171 to 180 of about 61,456 (351)
Controlled Ileal Release Budesonide in Pediatric Crohn Disease: Efficacy and Effect on Growth
P. Kundhal +3 more
openalex +1 more source
Microbial keystone species and gut microbiota composition are highly variable during the pathological development of the behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD). Age stratification reveals stage‐specific gut microbial signatures in AD‐related BPSD.
Fu‐You Su +7 more
wiley +1 more source
Vulvar Crohn disease: A case report. [PDF]
Kreutz J, Jensen C, Dytoc M.
europepmc +1 more source
Predictive Value of Laboratory Assays Toward Autoimmune Diseases
With an increasing number of unmet medical needs for autoimmune diseases (AD) in the United States, it is important to assess the value of laboratory assays in diagnosis. Healthcare providers must understand general and specific laboratory results that can lead to an efficient diagnosis.
Kellen J. Begeman +3 more
wiley +1 more source
A Therapeutic Tightrope: Managing Coexisting Crohn Disease and Systemic Lupus Erythematosus With Risankizumab. [PDF]
AlAwadhi H +6 more
europepmc +1 more source
Monoclonal antibodies against the Crohn´s disease - involved pancreatic autoantigen [PDF]
Horbach, E. +5 more
core +1 more source
Abstract Many patients with inflammatory bowel disease (IBD) do not adequately respond to infliximab, potentially due to individual differences in pharmacokinetics (PK). This study aimed to identify clinical and biochemical variables associated with infliximab PK.
Ilse A. Pool +6 more
wiley +1 more source

